Financial News
Endo Int'l Plc (NQ: ENDP )
6.695
USD
-0.155
(-2.26%)
Streaming Delayed Price
Updated: 12:58 PM EST, Mar 4, 2021
Add to My Watchlist
Press releases about Endo Int'l Plc
From PR Newswire
Endo Reports Fourth-Quarter And Full-Year 2020 Financial Results And Introduces 2021 Financial Guidance
February 25, 2021
From PR Newswire
Endo to Participate at J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference
February 17, 2021
From PR Newswire
Endo Appoints Jennifer M. Chao to Board of Directors
February 17, 2021
From PR Newswire
Endo to Announce Fourth-Quarter and Full-Year 2020 Financial Results
January 26, 2021
From PR Newswire
Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize Abaloparatide in Canada
January 05, 2021
From PR Newswire
Endo Aesthetics Launches "Really Cellulite" Campaign
January 05, 2021
From PR Newswire
Endo Launches Authorized Generic Version of Amitiza® (lubiprostone) Capsules in the United States
January 04, 2021
From PR Newswire
Endo to Participate at J.P. Morgan 39th Annual Healthcare Conference
December 18, 2020
From PR Newswire
POINT Biopharma Announces New Board Appointments
December 09, 2020
BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals
December 02, 2020
From PR Newswire
Endo Completes Acquisition of BioSpecifics
December 02, 2020
From PR Newswire
Endo to Participate In Upcoming Investor Conferences
November 18, 2020
From PR Newswire
Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer
November 18, 2020
From PR Newswire
BioSpecifics Reports Third Quarter 2020 Financial and Operating Results
November 09, 2020
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors Of Investigation of BioSpecifics Technologies Corp. Buyout
November 06, 2020
From PR Newswire
Endo Reports Third-Quarter 2020 Financial Results And Raises Full Year 2020 Financial Guidance
November 05, 2020
From PR Newswire
Endo Announces Strategic Actions to Further Position the Company for Long-Term Success
November 05, 2020
From PR Newswire
Isofol announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada
November 02, 2020
From PR Newswire
From PR Newswire
Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.
November 02, 2020
From PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of BioSpecifics Technologies Corp.
October 19, 2020
From PR Newswire
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.